Nutt, David J.

A review of the current nomenclature for psychotropic agents and an introduction to the Neuroscience-based Nomenclature

Zohar, J., Stahl, S., Moller, H.-J., Blier, P., Kupfer, D., Yamawaki, S., Uchida, H., Spedding, M., Goodwin, G. M., & Nutt, D. (2015) · European Neuropsychopharmacology

Treatment of Major DepressionMedical and Pharmaceutic Studies

Cited by 186

Biological markers of generalized anxiety disorder

Maron, E., & Nutt, D. (2017) · Dialogues in Clinical Neuroscience

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesNeurotransmitter Receptor Influence on Behavior

Cited by 164

Searching for perfect sleep: the continuing evolution of GABA A receptor modulators as hypnotics

Nutt, D. J., & Stahl, S. M. (2010) · Journal of Psychopharmacology

Sleep and related disordersNeuroscience and Neuropharmacology Research

Cited by 163

The Australian drug harms ranking study

Bonomo, Y., Norman, A., Biondo, S., Bruno, R., Daglish, M., Dawe, S., Egerton-Warburton, D., Karro, J., Kim, C., Lenton, S., et al. (2019) · Journal of Psychopharmacology

Substance Abuse Treatment and OutcomesOpioid Use Disorder Treatment

Cited by 154

Clinical Evidence and Potential Neurobiological Underpinnings of Unresolved Symptoms of Depression

Trivedi, M. H., Hollander, E., Nutt, D., & Blier, P. (2008) · The Journal of Clinical Psychiatry

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 153

Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse

Korpi, E. R., den Hollander, B., Farooq, U., Vashchinkina, E., Rajkumar, R., Nutt, D. J., Hyytiä, P., & Dawe, G. S. (2015) · Pharmacological Reviews

Neurotransmitter Receptor Influence on BehaviorNeuroscience and Neuropharmacology Research

Cited by 148

A review of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy

Sessa, B., Higbed, L., & Nutt, D. (2019) · Frontiers in Psychiatry

Psychedelics and Drug StudiesPosttraumatic Stress Disorder Research

Cited by 141

Acute Tryptophan Depletion. Part I: Rationale and Methodology

Hood, S. D., Bell, C. J., & Nutt, D. J. (2005) · Australian & New Zealand Journal of Psychiatry

Tryptophan and brain disordersNeurotransmitter Receptor Influence on Behavior

Cited by 135

Orexin-A Infusion in the Locus Ceruleus Triggers Norepinephrine (NE) Release and NE-Induced Long-Term Potentiation in the Dentate Gyrus

Walling, S. G., Nutt, D. J., Lalies, M. D., & Harley, C. W. (2004) · The Journal of Neuroscience

Sleep and Wakefulness ResearchNeuroscience and Neuropharmacology Research

Cited by 134

The blind men and the elephant: Systematic review of systematic reviews of cannabis use related health harms

Campeny, E., López-Pelayo, H., Nutt, D., Blithikioti, C., Oliveras, C., Nuño, L., Maldonado, R., Florez, G., Arias, F., Fernández-Artamendi, S., et al. (2020) · European Neuropsychopharmacology

Cannabis and Cannabinoid ResearchSubstance Abuse Treatment and Outcomes

Cited by 127

Correlation of subjective and objective sleep measurements at different stages of the treatment of depression

Argyropoulos, S. V., Hicks, J. A., Nash, J. R., Bell, C. J., Rich, A. S., Nutt, D. J., & Wilson, S. J. (2003) · Psychiatry Research

Sleep and related disordersSleep and Wakefulness Research

Cited by 124

Innovative solutions to novel drug development in mental health

Insel, T. R., Voon, V., Nye, J. S., Brown, V. J., Altevogt, B. M., Bullmore, E. T., Goodwin, G. M., Howard, R. J., Kupfer, D. J., Malloch, G., et al. (2013) · Neuroscience & Biobehavioral Reviews

Treatment of Major DepressionSchizophrenia research and treatment

Cited by 124

Uncritical positive regard? Issues in the efficacy and safety of psychotherapy

Nutt, D. J., & Sharpe, M. (2008) · Journal of Psychopharmacology

Psychotherapy Techniques and ApplicationsTreatment of Major Depression

Cited by 123

Blunted Endogenous Opioid Release Following an Oral Amphetamine Challenge in Pathological Gamblers

Mick, I., Myers, J., Ramos, A. C., Stokes, P. R. A., Erritzoe, D., Colasanti, A., Gunn, R. N., Rabiner, E. A., Searle, G. E., Waldman, A. D., et al. (2016) · Neuropsychopharmacology

Gambling Behavior and TreatmentsNeurotransmitter Receptor Influence on Behavior

Cited by 112

The effect of acutely administered MDMA on subjective and BOLD-fMRI responses to favourite and worst autobiographical memories

Carhart-Harris, R. L., Wall, M. B., Erritzoe, D., Kaelen, M., Ferguson, B., De Meer, I., Tanner, M., Bloomfield, M., Williams, T. M., Bolstridge, M., et al. (2014) · The International Journal of Neuropsychopharmacology

Psychedelics and Drug StudiesMemory Processes and Influences

Cited by 108

Cytokine levels in euthymic bipolar patients

Guloksuz, S., Aktas Cetin, E., Cetin, T., Deniz, G., Oral, E. T., & Nutt, D. J. (2010) · Journal of Affective Disorders

Bipolar Disorder and TreatmentTryptophan and brain disorders

Cited by 102

DMT alters cortical travelling waves

Alamia, A., Timmermann, C., Nutt, D. J., VanRullen, R., & Carhart-Harris, R. L. (2020) · eLife

Psychedelics and Drug StudiesNeural dynamics and brain function

Cited by 97

Assessing expectancy and suggestibility in a trial of escitalopram v. psilocybin for depression

Szigeti, B., Weiss, B., Rosas, F. E., Erritzoe, D., Nutt, D., & Carhart-Harris, R. (2024) · Psychological Medicine

Psychedelics and Drug StudiesPain Management and Placebo Effect

Cited by 89

Randomised controlled study of sleep after nefazodone or paroxetine treatment in out-patients with depression

Hicks, J. A., Argyropoulos, S. V., Rich, A. S., Nash, J., Bell, C. J., Edwards, C., Nutt, D. J., & Wilson, S. J. (2002) · British Journal of Psychiatry

Sleep and related disordersTreatment of Major Depression

Cited by 84

Psychedelics therapeutics: What we know, what we think, and what we need to research

Nutt, D., Spriggs, M., & Erritzoe, D. (2023) · Neuropharmacology

Psychedelics and Drug StudiesTreatment of Major Depression

Cited by 84

Current controversies in medical cannabis: Recent developments in human clinical applications and potential therapeutics

Schlag, A. K., O'Sullivan, S. E., Zafar, R. R., & Nutt, D. J. (2021) · Neuropharmacology

Cannabis and Cannabinoid ResearchComplementary and Alternative Medicine Studies

Cited by 82

In vivo imaging of microglial activation by positron emission tomography with [11C]PBR28 in the 5XFAD model of Alzheimer's disease

Mirzaei, N., Tang, S. P., Ashworth, S., Coello, C., Plisson, C., Passchier, J., Selvaraj, V., Tyacke, R. J., Nutt, D. J., & Sastre, M. (2016) · Glia

Neuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatments

Cited by 82

Successful Treatment of Night Terrors and Somnambulism with Paroxetine

Lillywhite, A. R., Wilson, S. J., & Nutt, D. J. (1994) · British Journal of Psychiatry

Sleep and related disordersSleep and Wakefulness Research

Cited by 81

Study Protocol for “Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study”

Spriggs, M. J., Douglass, H. M., Park, R. J., Read, T., Danby, J. L., de Magalhães, F. J. C., Alderton, K. L., Williams, T. M., Blemings, A., Lafrance, A., et al. (2021) · Frontiers in Psychiatry

Psychedelics and Drug StudiesEating Disorders and Behaviors

Cited by 75